Rhenman & Partners Asset Management Ab Alkermes Plc. Transaction History
Rhenman & Partners Asset Management Ab
- $1.01 Billion
- Q2 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Alkermes Plc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 150,000 shares of ALKS stock, worth $3.86 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
150,000
Previous 110,000
36.36%
Holding current value
$3.86 Million
Previous $2.98 Million
21.43%
% of portfolio
0.36%
Previous 0.29%
Shares
23 transactions
Others Institutions Holding ALKS
# of Institutions
348Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$748 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$514 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$369 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$283 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$237 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.22B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...